SEROQUEL XR
NDC 61269-270, quetiapine, tablet, extended release, from H2-Pharma, LLC.
- Product NDC
- 61269-270
- Status
- Listed
- Labeler
- H2-Pharma, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022047
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61269-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- QUETIAPINE FUMARATE50 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61269-270-60 | 61269027060 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-270-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ab959a35-d0ba-4f18-8f2e-6619d88b16e3
Use it
Look up 61269-270 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61269-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61269-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.